CytoSorbents Corporation (CTSO)

[OtisCambell1234]

2 filter companies at this Oncology Investment conference. https://www.nyconcologyconference.com/copy-of-presenting-companies This company is of interest.

Immunicom has leveraged the latest, cutting-edge clinical research in immune regulatory pathways and their role in cancer and autoimmune disease to develop a revolutionary immunotherapy platform (Immunopheresis™) for treating cancer and other terminal diseases through a BLOOD FILTERING DEVICE. We filter a patient’s blood of "blocking proteins" released by cancer cells that suppress the immune system. Once these proteins are removed, the immune system naturally attacks the tumor and cancer. Immunicom is led by Amif Jafri, the Former Head of R&D of Cardinal Health. The company first target is STNFr. Immunicom is in patient in Mexico, and recently received breakthrough device designation from the FDA.